Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis

被引：0
|
作者：
Ceccarelli, M. [1 ,2 ]
Pavone, P. [3 ]
Rullo, E. Venanzi [4 ]
Nunnari, G. [4 ]
机构：
[1] Univ Catania, Dept Clin & Expt Med, Infect Dis Unit, Catania, Italy
[2] Univ Messina, Infect Dis Unit, Dept Biomed Dent Morphol & Funct Imaging Sci, Messina, Italy
[3] G Rodolico Univ Hosp, Pediat Unit, Catania, Italy
[4] Univ Messina, Dept Clin & Expt Med, Infect Dis Unit, Messina, Italy
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2021年 / 25卷 / 06期
关键词：
COVID-19;
D O I：
10.26355/eurrev_202103_25408
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2473 / 2474
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis
    Lu, J-M
    Zhou, A-F
    Zhang, X-B
    Xu, H.
    Wang, X-F
    Ye, Q-F
    Shang, F-N
    He, Y-L
    Ma, S-L
    Cui, Y-X
    Chen, R-J
    Li, X-Y
    Zhai, X-W
    Li, Z-P
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 549 - 555
  • [2] Reply Letter - "Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis"
    De Vito, A.
    Madeddu, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (05) : 2161 - 2162
  • [3] Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019
    Ye, X-T
    Luo, Y-L
    Xia, S-C
    Sun, Q-F
    Ding, J-G
    Zhou, Y.
    Chen, W.
    Wang, X-F
    Zhang, W-W
    Du, W-J
    Ruan, Z-W
    Hong, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (06) : 3390 - 3396
  • [4] Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study
    Squires, Kathleen E.
    Johnson, Margaret
    Yang, Rong
    Uy, Jonathan
    Sheppard, Louise
    Absalon, Judith
    McGrath, Donnie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (02) : 363 - 370
  • [5] Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019
    Xia, Qi
    Dai, Wanrong
    Xu, Kaijin
    Ni, Qin
    Li, Yongtao
    Liu, Jun
    Zhao, Hong
    Guo, Yongzheng
    Yu, Liang
    Yi, Ping
    Su, Junwei
    Lang, Guanjing
    Tao, Jingjing
    Shi, Ding
    Wu, Wenrui
    Wu, Xiaoxin
    Xu, Yan
    Xu, Min
    Yu, Ling
    Wang, Xiaoyan
    Cai, Hongliu
    Fang, Qiang
    Zhou, Jianying
    Qiu, Yunqing
    Li, Lanjuan
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4446 - 4453
  • [6] Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial
    Shi, Nannan
    Guo, Lanping
    Liu, Bin
    Bian, Yongjun
    Chen, Renbo
    Chen, Suping
    Chen, Yang
    Chen, Yingying
    Cong, Xiaodong
    Dong, Guoju
    Guo, Jing
    Hu, Lijie
    Jiang, Jianxin
    Leng, Luxing
    Li, Bin
    Li, Dongxu
    Li, Hao
    Li, Jing
    Li, Li
    Liu, Jia
    Lu, Cheng
    Lv, Wenliang
    Miao, Qing
    Qi, Wensheng
    Shi, Zhan
    Shi, Jiaheng
    Shi, Huaxin
    Tian, Yaxin
    Wang, Bing
    Wang, Gang
    Wang, Jian
    Wang, Wei
    Xian, Yongyue
    Xie, Xiaolei
    Xiong, Yibai
    Xu, Chunyan
    Xu, Ming
    Yan, Bei
    Yang, Jinliang
    Zhang, Li
    Zhou, Zhenqi
    Zhu, Haoning
    Huang, Luqi
    PHYTOMEDICINE, 2021, 81
  • [7] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
  • [8] Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019
    Yu, Miao
    Wang, Deng-Chao
    Li, Sheng
    Lei, Yue-Hua
    Wei, Jian
    Huang, Li-Yan
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1513 - 1522
  • [9] Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients
    Biswas, Mohitosh
    PHARMACOGENOMICS, 2021, 22 (06) : 375 - 381
  • [10] Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
    ZengYan-Ming
    XuXiao-Lei
    HeXiao-Qing
    TangSheng-Quan
    LiYao
    HuangYin-Qiu
    HarypursatVijay
    ChenYao-Kai
    中华医学杂志英文版, 2020, 133 (09) : 1132 - 1133-1134
12345